Blog
RSS FeedPosted by Michael Wonder on 20 Mar 2020
Coronavirus vindicates capitalism
19 March 2020 - Drug companies will save lives, even as Bernie Sanders is denouncing them. ...
Posted by Michael Wonder on 19 Mar 2020
FDA to fast track clinical trials for coronavirus therapies
19 March 2020 - FDA Commissioner Stephen Hahn said the agency will test chloroquine, an anti-malarial drug, as a coronavirus treatment. ...
Posted by Michael Wonder on 19 Mar 2020
Coronavirus: Donald Trump announces two drugs will be made available to treat illness
20 March 2020 - Donald Trump has announced two “game changer” drugs will be made available “almost immediately” to treat coronavirus. ...
Posted by Michael Wonder on 19 Mar 2020
Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments
19 March 2020 - EMA’s Human Medicines Committee has published a statement urging the EU research community to prioritise large randomised ...
Posted by Michael Wonder on 19 Mar 2020
Coronavirus (COVID-19) update: FDA continues to facilitate development of treatments
19 March 2020 - The U.S. FDA continues to play a critical role in the multifaceted all-of-government response to the ...
Posted by Michael Wonder on 19 Mar 2020
FDA approves new treatment for paediatric patients with any strain of hepatitis C
19 March 2020 - The U.S. Food and Drug Administration today approved a supplemental application for Epclusa (sofosbuvir and velpatasvir) to ...
Posted by Michael Wonder on 19 Mar 2020
Limits on dispensing and sales of prescription and over-the-counter medicines
19 March 2020 - In order to ensure equitable access to medicines for all Australians, the Pharmacy Guild of Australia ...
Posted by Michael Wonder on 19 Mar 2020
Limits on dispensing and sales of medicines
19 March 2020 - Medicine supplies in Australia are strong however demand for medicines has increased markedly over the past two ...
Posted by Michael Wonder on 19 Mar 2020
Janssen submits ponesimod new drug application to the U.S. FDA for treatment of adults with relapsing multiple sclerosis
19 March 2020 - Janssen today announced the submission of a new drug application to the U.S. FDA for ponesimod ...
Posted by Michael Wonder on 18 Mar 2020
Coronavirus (COVID-19) update: FDA focuses on safety of regulated products while scaling back domestic inspections
18 March 2020 - Protecting the health and safety of our staff and their families is of paramount concern to ...
Posted by Michael Wonder on 18 Mar 2020
Biohaven's verdiperstat receives fast track designation for the treatment of multiple system atrophy
18 March 2020 - Biohaven Pharmaceutical announced today that the Company's myeloperoxidase inhibitor, verdiperstat, received Fast Track designation from the US ...
Posted by Michael Wonder on 18 Mar 2020
Hundreds of scientists scramble to find a Coronavirus treatment
17 March 2020 - In an ambitious international collaboration, researchers have “mapped” proteins in the coronavirus and identified 50 drugs to ...
Posted by Michael Wonder on 18 Mar 2020
Coronavirus (COVID-19) update: FDA issues guidance for conducting clinical trials
18 March 2020 - The U.S. Food and Drug Administration today issued a guidance for industry, investigators and institutional review ...
Posted by Michael Wonder on 18 Mar 2020
First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development
18 March 2020 - Today, the first global regulatory workshop on COVID-19, was convened under the umbrella of the International Coalition ...
Posted by Michael Wonder on 18 Mar 2020
EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19
18 March 2020 - EMA is aware of reports, especially on social media, which raise questions about whether non-steroidal anti-inflammatory ...